|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
| PMC |
7205724 |
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppr |
29.5 KB |
2020-12-29 |
|
40 |
|
14,319 |
| PMC |
7199903 |
Site-specific glycan analysis of the SARS-CoV-2 spike
SARS-CoV-2 spike protein, elaborated
Vaccine |
17.9 KB |
2020-09-27 |
|
39 |
|
8,102 |
| PMC |
7253482 |
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Abstract
Severe acute |
37 KB |
2020-09-27 |
|
37 |
|
12,807 |
| PMC |
7441788 |
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
J. SUN ET AL |
42.1 KB |
2020-09-27 |
|
37 |
|
4,581 |
| PMC |
7228307 |
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
FcγR an |
60.9 KB |
2020-09-27 |
|
37 |
|
7,109 |
| PMC |
7361216 |
A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan t |
9.26 KB |
2020-11-19 |
|
36 |
|
1,120 |
| PMC |
1064873 |
Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytoki |
35.9 KB |
2020-09-18 |
|
34 |
|
48,505 |
| PMC |
1064895 |
Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-depend |
29.3 KB |
2020-09-18 |
|
32 |
|
35,218 |
| PMC |
3589482 |
The Transcription Factor C/EBP-β Mediates Constitutive and LPS-Inducible Transcription of Murine Ser |
47 KB |
2020-09-18 |
|
31 |
|
46,492 |
| PMC |
1472690 |
β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflamm |
41.2 KB |
2020-10-02 |
|
30 |
|
44,468 |
